Advisory Board Votes For FDA To Take Makena, Drug To Prevent Preterm Birth, Off Market

An FDA advisory board voted for a preterm prevention drug to be taken off the market this week.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive